120 related articles for article (PubMed ID: 17047023)
1. Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors.
Björklund P; Akerström G; Westin G
J Clin Endocrinol Metab; 2007 Jan; 92(1):338-44. PubMed ID: 17047023
[TBL] [Abstract][Full Text] [Related]
2. An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling.
Björklund P; Akerström G; Westin G
PLoS Med; 2007 Nov; 4(11):e328. PubMed ID: 18044981
[TBL] [Abstract][Full Text] [Related]
3. Activated beta-catenin in the novel human parathyroid tumor cell line sHPT-1.
Björklund P; Akerström G; Westin G
Biochem Biophys Res Commun; 2007 Jan; 352(2):532-6. PubMed ID: 17126301
[TBL] [Abstract][Full Text] [Related]
4. The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors.
Svedlund J; Barazeghi E; Stålberg P; Hellman P; Åkerström G; Björklund P; Westin G
Endocr Relat Cancer; 2014 Apr; 21(2):231-9. PubMed ID: 24292603
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915
[TBL] [Abstract][Full Text] [Related]
6. Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.
Starker LF; Fonseca AL; Akerström G; Björklund P; Westin G; Carling T
Endocrine; 2012 Dec; 42(3):612-5. PubMed ID: 22576020
[TBL] [Abstract][Full Text] [Related]
7. Aberrant WNT/β-catenin signaling in parathyroid carcinoma.
Svedlund J; Aurén M; Sundström M; Dralle H; Akerström G; Björklund P; Westin G
Mol Cancer; 2010 Nov; 9():294. PubMed ID: 21078161
[TBL] [Abstract][Full Text] [Related]
8. Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients.
Björklund P; Lindberg D; Akerström G; Westin G
Mol Cancer; 2008 Jun; 7():53. PubMed ID: 18541010
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.
Westin G
J Intern Med; 2016 Dec; 280(6):551-558. PubMed ID: 27071708
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas.
Cetani F; Pardi E; Banti C; Collecchi P; Viacava P; Borsari S; Fanelli G; Naccarato AG; Saponaro F; Berti P; Miccoli P; Pinchera A; Marcocci C
Endocr Relat Cancer; 2010 Mar; 17(1):1-6. PubMed ID: 19755524
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas.
Ikeda S; Ishizaki Y; Shimizu Y; Fujimori M; Ojima Y; Okajima M; Sugino K; Asahara T
Int J Oncol; 2002 Mar; 20(3):463-6. PubMed ID: 11836555
[TBL] [Abstract][Full Text] [Related]
12. Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.
Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2007 Apr; 92(4):1564-6. PubMed ID: 17284619
[TBL] [Abstract][Full Text] [Related]
13. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
[TBL] [Abstract][Full Text] [Related]
14. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
16. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
17. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
Correa P; Akerstrom G; Westin G
Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
[TBL] [Abstract][Full Text] [Related]
18. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.
Jilong Y; Jian W; Xiaoyan Z; Xiaoqiu L; Xiongzeng Z
Pathology; 2007 Jun; 39(3):319-25. PubMed ID: 17558858
[TBL] [Abstract][Full Text] [Related]
19. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]